![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: de Boer Douwe Bosman Ingrid
Publisher: Springer Publishing Company
ISSN: 0928-1231
Source: Pharmacy World and Science, Vol.26, Iss.2, 2004-04, pp. : 110-113
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metabolism of Designer Drugs of Abuse
Current Drug Metabolism, Vol. 6, Iss. 3, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
2C Series Phenethylamine Derivative Exposures in Texas
Substance Abuse, Vol. 34, Iss. 1, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metabolism of Designer Drugs of Abuse: An Updated Review
Current Drug Metabolism, Vol. 11, Iss. 5, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PHARMAKON, Vol. 1, Iss. 6, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Nutt David
Journal of Substance Use, Vol. 8, Iss. 4, 2003-12 ,pp. :